Use of new CORE risk score to predict 10 year risk of liver cirrhosis in general population: population based cohort study
The CORE model, based on a flexible modelling approach and using biomarkers easily accessible in primary care, outperforms FIB-4 when predicting liver related outcomes in the general population and could be a novel means to stratify patients at risk for liver disease in the general population.
Authors
- Fredrik O. Åberg (ORCID: https://orcid.org/0000-0002-3833-0705)
- Veikko Salomaa
- Mats Talbäck (ORCID: https://orcid.org/0000-0002-5361-1142)
- Antti Jula (ORCID: https://orcid.org/0000-0002-3522-5301)
- Satu Männistö (ORCID: https://orcid.org/0000-0002-8668-3046)
- Panu K. Luukkonen (ORCID: https://orcid.org/0000-0003-2085-679X)
- Hannes Hagström (ORCID: https://orcid.org/0000-0002-8474-1759)
- Annamari Lundqvist (ORCID: https://orcid.org/0000-0002-0262-8585)
- Niklas Hammar (ORCID: https://orcid.org/0000-0001-5674-877X)
- Rickard Strandberg (ORCID: https://orcid.org/0000-0001-8960-3497)
- Juho Asteljoki
- Markus Perola
Institutions
- Karolinska University Hospital (SE)
- University of Helsinki (FI)
- Helsinki University Hospital (FI)
- Karolinska Institutet (SE)
- Finnish Institute for Health and Welfare (FI)
- Minerva Foundation (FI)
Publication Details
- Journal
- BMJ
- Published
- 2025-09-29
- DOI
- https://doi.org/10.1136/bmj-2024-083182
- Citations
- 6
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 8.13
Funders
- Wilhelm och Else Stockmanns Stiftelse
- Finska Läkaresällskapet
- Swedish Cancer Foundation
- Novo Nordisk
- Stockholms Läns Landsting
- Vetenskapsrådet
- Sigrid Juséliuksen Säätiö
- Novo Nordisk Fonden